1. Home
  2. ENTA vs PSFE Comparison

ENTA vs PSFE Comparison

Compare ENTA & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.70

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Logo Paysafe Limited

PSFE

Paysafe Limited

HOLD

Current Price

$6.92

Market Cap

390.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
PSFE
Founded
1995
1996
Country
United States
United Kingdom
Employees
N/A
2900
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
486.3M
390.7M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
PSFE
Price
$12.70
$6.92
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
$20.40
$10.15
AVG Volume (30 Days)
155.3K
462.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.93
N/A
EPS
N/A
N/A
Revenue
$102,814,000.00
N/A
Revenue This Year
$5.91
$8.50
Revenue Next Year
N/A
$5.85
P/E Ratio
N/A
N/A
Revenue Growth
16.48
N/A
52 Week Low
$4.09
$5.95
52 Week High
$17.15
$18.15

Technical Indicators

Market Signals
Indicator
ENTA
PSFE
Relative Strength Index (RSI) 41.06 47.58
Support Level $12.09 $6.58
Resistance Level $15.52 $7.62
Average True Range (ATR) 0.81 0.43
MACD -0.15 0.06
Stochastic Oscillator 4.86 48.15

Price Performance

Historical Comparison
ENTA
PSFE

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About PSFE Paysafe Limited

Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.

Share on Social Networks: